Anxiety, defence and the elevated plus-maze
Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety
Corticosterone response to the plus-maze High correlation with risk assessment in rats and mice
Orexins and appetite regulation
Ethopharmacological analysis of the effects of putative ‘anxiogenic’ agents in the mouse elevated plus-maze
Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze
Responses of Swiss–Webster Mice to Repeated Plus-Maze Experience Further Evidence for a Qualitative Shift in Emotional State?
Behavioral profile of wild mice in the elevated plus-maze test for anxiety
Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations
Exposure to the elevated plus-maze test of anxiety induced a mild, though enduring, elevation in tail-flick latencies in male mice, supported by the failure of chronic morphine treatment to alter either the antinociceptive or behavioural response to EPM exposure.
GABAergic influences on plus-maze behaviour in mice
Results confirmed the anxiolytic profile of diazepam under present test conditions, and revealed substantially similar effects for the GABA-T inhibitor, valproic acid, and the GABAA receptor agonist, muscimol while the GABAB receptor antagonist was inactive over the dose range studied.